Key statistics
As of last trade BioMarin Pharmaceutical Inc (BM8:BRN) traded at 42.76, 1.17% above its 52-week low of 42.27, set on Oct 13, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 42.76 |
|---|---|
| High | 42.76 |
| Low | 42.76 |
| Bid | 42.70 |
| Offer | 43.33 |
| Previous close | 42.76 |
| Average volume | -- |
|---|---|
| Shares outstanding | 192.11m |
| Free float | 190.68m |
| P/E (TTM) | 22.36 |
| Market cap | 11.46bn USD |
| EPS (TTM) | 2.67 USD |
Data delayed at least 15 minutes, as of Jan 19 2026.
More ▼
Press releases
- BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility
- BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility
- BioMarin Appoints Arpit Davé Chief Digital and Information Officer
- BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
- Veeva and BioMarin Form Long-Term Strategic Partnership
- Veeva and BioMarin Form Long-Term Strategic Partnership
- BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
More ▼
